We're looking for people to take part in a new clinical study
Find Out More
RSV is a common cold-like virus that affects the airways of the lungs. We are seeking volunteers to take part in a new clinical study.
See if you qualify
Study participants will receive COVID-19 study-related care at no cost.
Clinical research studies to learn about potential new vaccines, including boosters and vaccines against variants of the virus, are enrolling.
Help us find a way to speed up recovery from COVID-19 and reduce the need for hospital care.
The majority of clinical studies continue to move forward during the COVID-19 pandemic. Study teams are working closely with participants to ensure patient safety while meeting trial goals for successful clinical research.
Most healthcare facilities remain open in most areas, however many of them have changed their hours and have new procedures to ensure safety for trial participants.
Some study doctors may suggest televisits (phone or video call) so that patients can still attend scheduled visits without having to leave home.
If you are currently enrolled in a clinical trial, be sure to speak with your doctor about the status of your study and discuss any changes that have been put in place due to the novel coronavirus, SARS-CoV-2.
Clinical research is vital to the development of new medical treatments. Clinical research is the study of medical conditions in people, which enables researchers to gather valuable knowledge to advance medical insights around the world. Without clinical research trials, advances in healthcare and medical treatments would not be possible.
Find out more about clinical trials >Gain insights into:
Potential blood test may help doctors detect Alzheimer’s disease before the damage is done
Discover some common early symptoms and signs of Alzheimer's dementia
Could a more personalized treatment plan be needed?
Finnish clinical trials to study enterovirus vaccine, to see if it may help prevent type 1 diabetes
Can what you eat make a difference?
Avise: a new lupus test that may help speed up an accurate diagnosis
Researchers need to learn more about the number of people with multiple sclerosis
Preliminary results suggest reversing symptoms may be possible
Losing excess weight together with an active lifestyle remains the best way to help NASH patients
Pharmaceutical companies are rushing to fill the NASH treatment gap
CRCs are the face of clinical trials – meet Arielle Lapid
Are new treatment options on the horizon?
Shaping the future — working to advance the development of biologic therapies
Register to get notifications about clinical trials in your area.
Register to Receive Updates
Moving from preventing relapse to reducing disability
Exploring new mechanisms of action and a patient-centered approach
A breakthrough could be on the horizon
English (USA)